Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Committee Recommends Avelox For Respiratory Tract Infections SILVER SPRING, MD. -- October 22, 1999 -- An advisory committee to the U.S. Food and Drug Administration (FDA) today recommended approval of Avelox™ (moxifloxacin HCl), a new quinolone antibiotic developed by Bayer, for the treatment of acute sinusitis, acute bacterial exacerbations of chronic bronchitis (ABECB), community-acquired pneumonia, and uncomplicated skin and skin structure infections. "We are very pleased that after reviewing the data, the FDA advisory committee has recognized the value of Avelox for treatment of many common community-acquired respiratory tract infections," said Lawrence E Posner, MD, senior vice president, pharmaceutical development, Bayer Corporation, Pharmaceutical Division. "Many of the pathogens responsible for community-acquired respiratory tract infections have developed resistance to the most commonly prescribed antibiotics, creating a real and very immediate need for new agents to fill the void." Bayer presented data for Avelox based on clinical trials involving nearly 8,000 patients. In these trials, Avelox was evaluated for efficacy in eradicating pathogens such as S pneumoniae, H influenzae, and M catarrhalis, as well as atypical bacteria. If the FDA accepts the recommendation of its advisory committee, Avelox could be approved for marketing before the end of 1999. Avelox has been approved for marketing in eight countries, including Germany and Switzerland. Related Link: Bayer Corporation. E-mail this page to a friend or colleague! To print, use this version